Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Granted U.S. Patent for Deuterated DMT
March 3, 2022
Company announced the first officially issued patent Patent provides strong protection for Cybin’s growing IP portfolio of psychedelic-based compounds CYB004 has demonstrated potential efficacy at lower doses while increasing duration of drug effect that may alleviate common negative experiences In a milestone moment for psychedelic therapeutics company Cybin (NEO: CYBN) (NYSE American: CYBN), the company has […]
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Dosing of First Patient in Acclaim-1 Clinical Trial
March 2, 2022
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced that the first patient was dosed in the Acclaim-1 clinical trial. The open-label, multi-center phase 1/2 clinical trial will evaluate the company’s lead drug candidate, REQORSA(TM) Immunogene Therapy, in combination with Tagrisso(R) (osimertinib) in […]
InvestorNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Marks Key Milestone Within Comprehensive Strategy for Ibogaine Program
March 2, 2022
Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE”), a leader in advanced proprietary technology for mental health care and research in psychedelics, today announced that it has developed a number of non-racemic mixtures of ibogaine and has filed a provisional patent for these mixtures and their therapeutic use in treating a range of […]
Cepton Inc. (NASDAQ: CPTN) Hits Wall Street After Successful SPAC Merger; Initial Market Capitalization More Than Doubled Since Last Private Valuation
March 2, 2022
Cepton makes public debut after completing business combination with GCAC; appears on track to deliver on its vision to expand leading market position and drive value for stakeholders With initial market capitalization of around $1.4 billion, Cepton more than doubled its last private valuation of $615 million Company has grand plans for future; aims to […]
InvestorNewsBreaks – StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Targeting Cash Flow Generation, Leveraging Advanced Technology to Guide Explorational Focus
March 1, 2022
StraightUp Resources (CSE: ST) (OTCQB: STUPF), a company that has, since inception, remained committed to mineral exploration as well as the acquisition of mineral property assets both in North and South America, now seeks to tap into expected growth trends while generating cash flow. StraightUp has been on an aggressive campaign to secure properties in […]
IBN (InvestorBrandNetwork) Announces NetworkNewsAudio Interview featuring Suji Desilva, Senior Research Analyst at Roth Capital Partners
March 1, 2022
NEW YORK, March 01, 2022 (GLOBE NEWSWIRE) — via InvestorWire — IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest NetworkNewsAudio interview as part of its sustained effort to provide specialized content distribution via widespread syndication channels. NetworkNewsAudio, a service of NetworkNewsWire (NNW), allows you to sit […]
InvestorNewsBreaks – Friendable Inc. (FDBL) Completes Phase One Development, Looking to Phase Two
March 1, 2022
Friendable (OTC: FDBL), a mobile technology and marketing company, has reached a significant milestone with the completion of the first-phase development of its Fan Pass platform. That phase included livestream and music distribution service offerings, websites, revenues and a compelling business combination in general. According to the announcement, the company has now positioned its Fan Pass […]
Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Now Controls All Aspects of its Michigan Operations Following PharmaCo’s Acquisition
March 1, 2022
RWB has received all regulatory approvals and closed its acquisition of PharmaCo, a Michigan-based marijuana company This acquisition opens RWB to over 22 properties, including dispensaries and cultivation sites, giving it complete control of all its operations, from cultivating the product to selling it It marks a key milestone for the company and its shareholders […]
InvestorNewsBreaks – PowerTap Hydrogen Capital Corp.’s (NEO: MOVE) (OTC: MOTNF) (FWB: 2K6) Portfolio Company Rebranded to Suit Disruptive Technology
February 28, 2022
Aberdeen International Inc. (TSX: AAB) (OTC: AABVF) (FR: A8H) today announced the rebranding of its portfolio company, AES-100 Inc., to Progressus Clean Technologies(TM). Progressus is a private company with ownership held by PowerTap (NEO: MOVE) (OTC: MOTNF) (FWB: 2K6), Aberdeen International and a minority position being privately held. According to the update, the new name […]
Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Makes Exciting Drug Discovery for the Treatment of Mental health and Addiction Disorders – MYCO-005
February 28, 2022
Mydecine announced the inclusion of a patent-pending novel molecule in its family of psilocin analogs, MYCO-005 This molecule features potentially heart-safe microdose-enabling properties, addressing the delivery and stability concerns associated with the first-generation compounds Mydecine’s patent-pending dermal route to administration also offers more control over the drug while possibly eliminating undesirable properties such as nausea […]
InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Optimistic of Positive Study Results, Eyes ‘Most Exciting Year Ever’
February 25, 2022
Lexaria Bioscience Corp. (NASDAQ: LEXX) achieved myriad milestones in 2021, with CEO Chris Bunka noting in an annual letter to shareholders that January 2021 marked the birth of a modern version of the company. A recent article contains excerpts from the letter, in which Bunka writes, “During 2021, we completed research & development (‘R&D’) and […]
Nemaura Medical Inc. (NASDAQ: NMRD) Publishes 3QFY2022 Results; Company Reports its Inaugural Quarterly Revenues
February 25, 2022
Nemaura Medical has recently reported its 3QFY2022 (4QCY2021) results, with the company recognizing its inaugural revenues of $183,628 over the quarter The company also announced that it held $23 million in cash reserves as of the end of the quarter, which should amply cover its cash requirements over the coming months Nemaura Medical seized upon […]
InvestorNewsBreaks – Standard Lithium Ltd. (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L) Eyes Clear Path Towards Delivering New US Commercial Lithium Production
February 24, 2022
Standard Lithium (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L), an innovative technology and lithium project development company, today announced that it has reached an agreement with its strategic partner, LANXESS Corporation, that streamlines and expedites the plan for development of the first commercial lithium project in Arkansas. The project is to be constructed at an […]
With Bulls on the Side of Gold Trends, StraightUp Resources Inc.’s (CSE: ST) (OTCQB: STUPF) Charges Ahead with Greenstone Belt Drill Plans
February 24, 2022
Metals exploration and acquisition company StraightUp Resources has spent recent months optioning potential drill sites in the gold-producing region of Ontario’s famed Red Lake Mining District StraightUp conducted ground and airborne magnetic surveys last year to help guide its strategy for potential exploration, with results showing some “high merit” areas of potential mineralization The company […]
Lexaria Bioscience Corp. (NASDAQ: LEXX) Optimistic About its Expanded DehydraTECH Investigations; Plans for More Studies in 2022
February 23, 2022
Lexaria just announced ground-breaking findings from its recently-concluded Sildenafil animal study The success of this study sets the stage for various other studies on the use of the company’s patented DehydraTECH technology The company is set to commence dosing its most extensive hypertension study in April 2022, with results expected in Q3 2022 Its successful […]
InvestorNewsBreaks – AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) Achieves New Milestone, Opens Additional Revenue Stream
February 23, 2022
AREV Life Sciences (CSE: AREV) (OTC: AREVF) today announced completion of its fungi inoculation lab, colonizing and fruiting rooms. According to the update, the fruiting room has been populated with colonized blocks of Lion’s Mane (Hericium erinaceus) containing bioactive substances with beneficial effects on the body, especially the brain, heart and gut. “This is another […]
AREV Life Sciences Completes Lab and Fungi Fruiting Room Build
February 23, 2022
VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) — via InvestorWire – AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) announces today completion of its fungi inoculation lab, colonizing and fruiting rooms. The fruiting room has been populated with colonized blocks of Lion’s Mane (Hericium erinaceus) containing bioactive substances with beneficial effects […]
InvestorNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Updates on Psychedelic Medicine Programs Progess, Novel Compounds Milestone
February 22, 2022
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, has released an update regarding its wholly owned subsidiary XPhyto Laboratories Inc. XPhyto Labs’ psychedelic medicine programs are focused on a multipronged approach to psychedelic medicine and include GMP (“GMP”) drug synthesis, proprietary drug-delivery systems, novel psychedelic […]
AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) Is ‘One to Watch’
February 22, 2022
In the first quarter of 2022, AREV acquired Wright & Well Essentials Inc., a firm with an extensive hemp and cannabis line of branded products currently sold in Oregon and expanding markets. The company’s online sales and marketing platform, Medicine Merchant™, is in the final stages of development; the platform has the potential to revolutionize […]
Billion-Dollar Acquisition, Region’s History, Survey Results, Support StraightUp Resources Inc.’s (CSE: ST) (OTCQB: STUPF) Focus on the Prolific Red Lake District
February 22, 2022
StraightUp Resources has optioned or acquired several properties in the historic Red Lake District in Ontario, which has produced over 30 million ounces of gold to date The company’s properties in the area include RLX North, RLX South, Belanger, and Ferdinand properties Late last year, a senior gold mining company entered into an agreement to […]
InvestorNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Eyes Continued Expansion on Rapidly Growing Lightning Network
February 18, 2022
LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network, is uniquely positioned to further drive Bitcoin adoption. Although considered rather volatile, Bitcoin, in the long-term, could stand up against the inflation rates created by the mass production of fiat currencies. It is also […]
InvestorNewsBreaks – Hollywall Entertainment Inc. (HWAL) Empowering Communities with Fiber to the People(TM)
February 18, 2022
Hollywall Entertainment (OTC: HWAL) exemplifies the idea that rural, often poor communities deserve the freedom to move beyond the boundaries of their neighborhoods, not only on roads but also via high-speed computer connections. Darnell Sutton, the company’s president and CEO, has long pursued Fiber to the People(TM) — an effort to empower smaller communities. A […]
InvestorNewsBreaks – Triccar Inc. (CIPI) Changes Name, Files 14C Information Statement
February 18, 2022
Triccar (OTCQB: CIPI) announced that a majority of shareholders have approved the company’s proposed name change from Triccar Inc. to Correlate Infrastructure Partners Inc.; that approval was received through written consent. In addition, the company announced that it has filed a Form 14C Information Statement with the Securities Exchange Commission (“SEC”) and will be mailing […]
InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Reports Achievement of Additional Adelia Milestone
February 18, 2022
Cybin (NEO: CYBN) (NYSE American: CYBN),a biopharmaceutical company focused has announced that subsidiary Adelia Therapeutics Inc. has achieved a milestone outlined in the contribution agreement between Cybin, Cybin Corp., Cybin US Holdings Inc. and previous Adelia shareholders; the milestone was identified as Year 2 Q2 (iii). According to the transaction agreement, 17,239.5 Cybin class B common […]
InvestorNewsBreaks – StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Strengthens Commitment to Red Lake Mining District
February 17, 2022
StraightUp Resources (CSE: ST) (OTCQB: STUPF) has entered 2022 with a tailwind driving enthusiasm around its gold prospects in Ontario’s famed greenstone belt and a historically metal-rich region in the western United States. “The Canada-headquartered mineral explorer has spent the last year steadily increasing its data on five gold properties it has optioned in Canada’s […]
InvestorNewsBreaks – Friendable Inc. (FDBL) Focused on Monetization, Building Scale on Heels of Major Accomplishments
February 17, 2022
Friendable (OTC: FDBL) is a mobile technology and marketing company focused on the development and identification of products, services and brand opportunities with mass-market potential and scalability. The company achieved significant milestones in 2021,including the release of a new Fan Pass Live on popular mobile app stores, as well as a new website version. The […]
InvestorNewsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) to Ring Bell, Open NASDAQ Market Today
February 17, 2022
Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance Micro Motion Technology(R) (“MMT”) lidar solutions was scheduled to ring the opening bell on the market today at 9:15 a.m. ET. The ceremonial bell-ringing activity marks the company’s official public listing on the NASDAQ market, which was a week ago on Feb. 11, 2022. […]
InvestorNewsBreaks – AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) Expands Corporate Efforts as It Advances Closer to Market with Milestone Products
February 17, 2022
AREV Life Sciences (CSE: AREV) (OTC: AREVF) today announced new corporate acquisitions and maturation of multiple product lines being matched with appointments and expanding corporate capacity in the company’s scientific advisory committee and IP council. The company has appointed Douglas Sorocco to its scientific advisory committee and IP council and has extended services with Strategic […]
InvestorNewsBreaks – Streamlytics Continues Rapid Growth to Surpass 5 Billion Cookieless 1st Party Data Points
February 17, 2022
Streamlytics, the largest first-party data provider of consumer cross-platform activity, continues its rapid growth of cookie-less first-party data. The company today announced that it has processed five billion first-party data points directly and ethically from consumers. This marks Streamlytics’ most recent achievement in a line of notable milestones coming on the heels of an industry […]
AREV Life Sciences Advances Developments, New Appointments and Relationships
February 17, 2022
VANCOUVER, British Columbia , Feb. 17, 2022 (GLOBE NEWSWIRE) — via InvestorWire – AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) today announces its new corporate acquisitions and maturation of multiple product lines that are being matched with appointments and expanding corporate capacity in the Company’s scientific advisory committee and IP council. […]
Streamlytics Surpasses 5 Billion Cookieless 1st Party Data Points Worldwide
February 16, 2022
Miami, Feb. 16, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Streamlytics, the largest first-party data provider of consumer cross-platform activity, continues its rapid growth of cookie-less 1st party data. Today, the company announced that it has processed five billion first-party data points directly and ethically from consumers. “Streamlytics is pioneering a new era of how consumer […]
Following Successful Sildenafil Animal Study, Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Plans for More Studies in 2022
February 16, 2022
Lexaria’s animal study could be the first step to developing faster and better acting sildenafil oral formulations The most prominent study for Lexaria in 2022 is HYPER-H21-4, investigating patented DehydraTECH(TM)-CBD for hypertension and heart disease Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced positive findings in an animal study that […]
IBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast featuring Dr. Harald Zink, CEO of SPYR Inc. Subsidiary Applied Magix Inc.
February 16, 2022
NEW YORK, Feb. 16, 2022 (GLOBE NEWSWIRE) — via InvestorWire – IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Bell2Bell Podcast delivers informative updates […]
ECGI Issues Shareholder Update Letter From the CEO
February 16, 2022
LOS ANGELES, Feb. 16, 2022 (GLOBE NEWSWIRE) — via InvestorWire – ECGI HOLDINGS INC. (OTC: ECGI) (“ECGI” or the “Company”), D/B/A Elite Cannabis Group Incorporated, a Nevada-based portfolio company pivoting into the legal cannabis and cannabinoid marketplace, is pleased to issue the following Letter to Shareholders from the Company’s CEO: Dear Valued Shareholder, I would […]
IBN (InvestorBrandNetwork) Announces Latest Episode of Stock2Me Podcast Featuring Return of FuelPositive Corp. CEO Ian Clifford
February 15, 2022
LOS ANGELES, Feb. 15, 2022 (GLOBE NEWSWIRE) — via InvestorWire — IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Stock2Me Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Stock2Me Podcast features a fascinating […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Reports Financial Results, Business Updates for Q3 2022
February 14, 2022
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and supporting personalized lifestyle coaching programs, has released its Q3 financial results and business updates. The company noted that, for the three-month period ending Dec. 31, 2021, highlights included the shipment of sugarBEAT(R) continuous glucose monitor (“CGM”) devices to its […]
InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) to Be Evaluated for Potential Treatment Options for Multiple Conditions
February 11, 2022
Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Chris Bunka noted that Lexaria would continue to see significant milestones in utilizing its patented DehydraTECH drug delivery technology in 2022. “Calendar 2022 will continue to see significant milestones utilizing DehydraTECH-CBD for investigation of heart disease and hypertension; and separately, for oral nicotine delivery as an alternative to smoking… […]
InvestorNewsBreaks – StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Greenlit to Proceed with Mechanized Drilling, Ground Geophysical Surveys at Flagship RLX Property
February 11, 2022
StraightUp Resources (CSE: ST) (OTCQB: STUPF) expects to proceed in its 2022 work programs for its flagship property, a 10,000-hectare tract of land located in the Red Lake District that has shown great promise in gold mining. The work programs include drilling the most prospective targets in the summer. This follows receipt of its early […]
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Releases Q3 2022 Financial Numbers, Corporate Update
February 11, 2022
VistaGen Therapeutics (NASDAQ: VTGN), a company developing therapeutics to transform the treatment paradigm for patients suffering from anxiety, depression and other central nervous system disorders, has reported its third-quarter 2022 financial and business status. Highlights of the report include the advancement of VTGN’s late-stage PH94B clinical program, including progress toward topline data readouts for phase […]
Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Marks Another Key Milestone in its 2022 Accelerated Distribution Plan Following Expansion Into HEB Grocery Stores
February 11, 2022
Eat Well Group’s majority-owned portfolio company, Amara, will now be available in 200 HEB grocery stores in the United States This move strengthens the company’s retail shelf footprint and adds to the growing number of brick and mortar stores stocking Amara products, including Walmart Canada, Whole Foods, Loblaws, and Sprouts Farmers’ Market Amara’s management is […]